Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies
Utthara Nayar(Broad Institute), Ofir Cohen(Broad Institute), Christian Kapstad(Broad Institute), Michael S. Cuoco(Broad Institute), Adrienne G. Waks(Broad Institute), Seth A. Wander(Broad Institute), Corrie Painter(Broad Institute), Samuel S. Freeman(Broad Institute), Nicole S. Persky(Broad Institute), Lori Marini(Dana-Farber Cancer Institute), Karla Helvie(Dana-Farber Cancer Institute), Nelly Oliver(Dana-Farber Cancer Institute), Orit Rozenblatt–Rosen(Broad Institute), X. Cynthia(Washington University in St. Louis), Aviv Regev(Broad Institute), Eric P. Winer(Brigham and Women's Hospital), Nancy U. Lin(Brigham and Women's Hospital), Nikhil Wagle(Broad Institute)
Cited by 238
Abstract
Related Papers
No related papers found
Powered by citation graph analysis